Aragan Chooses Slider Packaging for Probiotic Drug Relaunch

Burgopak Healthcare & Technology has been selected by Aragan, a French laboratory that specialises in the use of natural ingredients, to package the relaunch of its probiotic drug Restaure. The drug is a combination of two probiotic strains that help maintain or regain balance of intestinal microflora.

The product, which is available in pharmacies throughout France, utilises Burgopak’s patented slider packaging. To open the pack and access the product, the consumer pulls on a highlighted tab. The pack slides open to reveal the blistered product on one side with the consumer information on the other. To close the pack, the consumer simply pushes the tab back to its original position.

Nicolas Brodetsky, Managing Director at Aragan, said: “Initially, I was looking for a standard packaging system. In the OTC and food supplement market, it is necessary to offer the patient a real benefit to attract their attention. Burgopak provided the answer to this.”

The design of the pack is well suited for the modern consumer’s lifestyle. The functionality keeps the product, information and outer carton permanently connected. Important product information is readily available every time the pack is opened, encouraging the consumer to take the product as instructed. The design also eliminates unnecessary space, keeping the pack compact and portable, which is convenient for the consumer on the move. The slider design also provides maximum protection for the blister, reducing the risk of tablets being accidentally released.

In addition, the slider design adds value for brand owners. Printable areas on the pack offer maximum opportunity for brand communication. The sliding mechanism reportedly supplies a point of differentiation in a competitive market, encouraging consumers to engage with the product through the interactive opening and closing mechanism. The compactness of the design also optimises retail shelf space, while simultaneously reducing shipping costs.

Working closely with Aragan and its manufacturing partners, Burgopak completed the blister tooling development and manufacturing to deliver the final product three months from order placement. Brodetsky said: “In addition to a higher quality of product, Burgopak were extremely responsive throughout the entire process, helping to deliver the product within three weeks of the artwork being signed off." The quick turnaround of the project is testament to Burgopak’s commitment to design excellence, while also demonstrating efficiency in manufacturing processes.

Burgopak Ltd, +44 207 089 1950, pharma@burgopak.com, www.burgopakhealthcare.com.